Many Groups and Organizations respond on Policy Issues WASHINGTON, June 12, 2025 /PRNewswire/ -- The recent rapid approach to policy…
-PoNS Therapeutic Experience Program (PoNSTEP) study demonstrates durable long-term beneficial effects of PoNS Therapy® on gait deficit improvement in people…
-PoNS Therapeutic Experience Program (PoNSTEP) study demonstrates durable long-term beneficial effects of PoNS Therapy® on gait deficit improvement in people…
Funding supports pivotal Phase 3 trial for sovateltide, a potential first-in-class therapy that could transform the treatment of acute cerebral…
Dr. Jon Block to Lead Vivex’s Completion of its Ascend and Restore Randomized Clinical Trials for VIA Disc® NP, Vivex’s…
WELLESLEY, Mass. and NEW YORK, June 9, 2025 /PRNewswire/ -- Sun Life U.S., a top ten group benefits provider, and…
NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentations of data highlighting…
Patients on fenebrutinib had low relapse rates with data showing no active brain lesions or disability progression after nearly two…
CHICAGO, May 29, 2025 /PRNewswire/ -- RedMane Technology appointed Nick Cronshaw to a Sales Executive position focused on advancing the…
Together, They Aim to Solve One of America's Most Overlooked Health Crisis: Mold Toxicity LOS ANGELES, May 28, 2025 /PRNewswire/…